Luigi Naldini, PhD
Affiliations: | San Raffaele-Telethon Institute for Gene Therapy (TIGET) |
Google:
"Luigi Naldini"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Montini E, Naldini L, Booth C, et al. (2024) Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Calabria A, Spinozzi G, Cesana D, et al. (2024) Long-term lineage commitment in hematopoietic stem cell gene therapy. Nature |
Cesana D, Cicalese MP, Calabria A, et al. (2024) A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID. Nature Communications. 15: 3662 |
Milani M, Canepari C, Assanelli S, et al. (2024) GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice. Embo Molecular Medicine |
Castiello MC, Brandas C, Ferrari S, et al. (2024) Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency. Science Translational Medicine. 16: eadh8162 |
Canarutto D, Asperti C, Vavassori V, et al. (2023) Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4 T-cells for the treatment of Hyper IgM1. The Embo Journal. e114188 |
Kerzel T, Giacca G, Beretta S, et al. (2023) In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases. Cancer Cell. 41: 1892-1910.e10 |
Asperti C, Canarutto D, Porcellini S, et al. (2023) Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated and . Molecular Therapy. Methods & Clinical Development. 30: 546-557 |
Ferrari S, Naldini L. (2023) A step toward stem cell engineering in vivo. Science (New York, N.Y.). 381: 378-379 |
Canarutto D, Omer Javed A, Pedrazzani G, et al. (2023) Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation. British Medical Bulletin |